Search research articles
Contact Us
Filters
Showing results (11-20 of 90) with videos related to
Page
of 9
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
June 26, 2025
Incorporating Multiple Imputation Into Tanezumab Dose-Response Modeling of WOMAC Pain CFB Across Six Randomized Placebo-Controlled Phase 3 Trials
Martin Boucher, Scott Marshall, Puneet Gaitonde
Occupational and Environmental Medicine
|
November 20, 2008
The impact of temporary employment and job tenure on work-related sickness absence
E Tompa, H Scott-Marshall, M Fang
Work (Reading, Mass.)
|
October 28, 2010
Social protection and the employment contract: the impact on work absence
Emile Tompa, Heather Scott-Marshall, Miao Fang
British Journal of Clinical Pharmacology
|
September 25, 2024
Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus
Junyi Wu, Xuan Zhou, Richard Dimelow, et al.
Disability and Health Journal
|
December 25, 2012
Marital formation in individuals with work-related permanent impairment
Heather Scott-Marshall, Emile Tompa, Qing Liao, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 15, 2005
A longitudinal model for non-monotonic clinical assessment scale data
Fredrik Jonsson, Scott Marshall, Michael Krams, et al.
Briefings in Bioinformatics
|
March 14, 2009
Life sciences on the Semantic Web: the Neurocommons and beyond
Alan Ruttenberg, Jonathan A Rees, Matthias Samwald, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
November 4, 2014
Long-term mortality risk in individuals with permanent work-related impairment
Heather K Scott-Marshall, Emile Tompa, Ying Wang, et al.
British Journal of Clinical Pharmacology
|
October 10, 2013
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment
Elena Soto, Satoshi Shoji, Chieko Muto, et al.
Clinical Pharmacology and Therapeutics
|
April 18, 2019
Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout
Daniel Hill-McManus, Scott Marshall, Elena Soto, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 90) with videos related to
Sort By:
Page
of 9
CPT: Pharmacometrics & Systems Pharmacology
|
June 26, 2025
Incorporating Multiple Imputation Into Tanezumab Dose-Response Modeling of WOMAC Pain CFB Across Six Randomized Placebo-Controlled Phase 3 Trials
Martin Boucher, Scott Marshall, Puneet Gaitonde
Occupational and Environmental Medicine
|
November 20, 2008
The impact of temporary employment and job tenure on work-related sickness absence
E Tompa, H Scott-Marshall, M Fang
Work (Reading, Mass.)
|
October 28, 2010
Social protection and the employment contract: the impact on work absence
Emile Tompa, Heather Scott-Marshall, Miao Fang
British Journal of Clinical Pharmacology
|
September 25, 2024
Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus
Junyi Wu, Xuan Zhou, Richard Dimelow, et al.
Disability and Health Journal
|
December 25, 2012
Marital formation in individuals with work-related permanent impairment
Heather Scott-Marshall, Emile Tompa, Qing Liao, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
November 15, 2005
A longitudinal model for non-monotonic clinical assessment scale data
Fredrik Jonsson, Scott Marshall, Michael Krams, et al.
Briefings in Bioinformatics
|
March 14, 2009
Life sciences on the Semantic Web: the Neurocommons and beyond
Alan Ruttenberg, Jonathan A Rees, Matthias Samwald, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
November 4, 2014
Long-term mortality risk in individuals with permanent work-related impairment
Heather K Scott-Marshall, Emile Tompa, Ying Wang, et al.
British Journal of Clinical Pharmacology
|
October 10, 2013
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment
Elena Soto, Satoshi Shoji, Chieko Muto, et al.
Clinical Pharmacology and Therapeutics
|
April 18, 2019
Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout
Daniel Hill-McManus, Scott Marshall, Elena Soto, et al.
Page
of 9